Catabasis Pharmaceuticals

At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART linker platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.
Type
Public
HQ
Cambridge, US
Founded
2008
Size (employees)
37 (est)
Catabasis Pharmaceuticals was founded in 2008 and is headquartered in Cambridge, US

Catabasis Pharmaceuticals Office Locations

Catabasis Pharmaceuticals has an office in Cambridge
Cambridge, US (HQ)
B14202 One Kendall Square Binney St

Catabasis Pharmaceuticals Data and Metrics

Catabasis Pharmaceuticals Financial Metrics

$, USD

Net income (FY, 2016)

(36.1 m)

EBIT (FY, 2016)

(35.6 m)

Market capitalization (23-Jun-2017)

30.3 m

Closing share price (23-Jun-2017)

1.3

Cash (31-Dec-2016)

23.6 m
Catabasis Pharmaceuticals's current market capitalization is $30.3 m.
$, USDFY, 2015FY, 2016

R&D expense

23 m25.5 m

General and administrative expense

8.6 m10.1 m

Operating expense total

31.7 m35.6 m

EBIT

(31.7 m)(35.6 m)

Interest expense

(978 k)(837 k)

Net Income

(32.6 m)(36.1 m)
$, USDFY, 2015FY, 2016

Cash

62.8 m23.6 m

Inventories

804 k1 m

Current Assets

63.6 m39.5 m

PP&E

504 k568 k

Total Assets

64.2 m40.2 m

Accounts Payable

1.3 m1.4 m

Current Liabilities

7.8 m8.3 m

Additional Paid-in Capital

158.5 m173.1 m

Retained Earnings

(108 m)(144.1 m)

Total Equity

50.5 m29.1 m

Financial Leverage

1.3 x1.4 x
$, USDFY, 2015FY, 2016

Net Income

(32.6 m)(36.1 m)

Depreciation and Amortization

202 k395 k

Inventories

(450 k)(229 k)

Accounts Payable

196 k77 k

Cash From Operating Activities

(29.8 m)(32.9 m)

Purchases of PP&E

(421 k)(459 k)

Cash From Investing Activities

(421 k)(15.5 m)

Cash From Financing Activities

78.3 m9.2 m

Interest Paid

684 k582 k
Y, 2016

Financial Leverage

1.4 x

Catabasis Pharmaceuticals Market Value History

Catabasis Pharmaceuticals Online and Social Media Presence

Catabasis Pharmaceuticals Company Life and Culture

You may also be interested in